Around 1.6 million Americans are suffering from type 1 diabetes (T1D), an autoimmune disorder that leaves them unable to generate the insulin they need to keep their blood sugar at a safe and healthy level. The consequences of not treating T1D in a timely manner can be fatal. Right now keeping the condition under control requires regular testing of blood to determine if you need to inject insulin to keep the glucose levels healthy. But there are a number of new approaches in the pipeline, ones that might one day eliminate the need for regular testing and injections. In this episode we talk to two women at the forefront of this work and hear what it could mean for patients.